The total value of the global microfluidic devices market was USD 14,218.6 million in 2021, and it will rise at a growth rate of above 17.3% shortly, reaching USD 59,785.3 million by 2030, according to P&S Intelligence.
Microfluidics is a developing scientific area with an extensive variety of logical applications and commercial diagnoses in the arenas of cell biology research, protein crystallization, and medicine. Therefore, this technology is a vital tool to decrease side effects and advance the effectiveness of treatments.
Furthermore, the requirement for micromachined biological tools is projected to grow considerably in the coming few years, driven by the development of genomics and proteomics studies, and also the aimed incorporation of lab-on-a-chip tools into laboratory measures.
In Asia-Pacific, China is one of the fastest-rising industries for microfluidics because of the growing government backing and refining of healthcare amenities. Consequently, APAC is projected to arise as an appealing industry for businesses manufacturing like medicinal instruments.
Whereas, in Europe, the industry is boosted by the growing diagnosis needs, credited to the refining healthcare amenities and the increasing occurrence of illnesses; itself because of the lifestyle changes and elderly populace.
In 2021, the polymer category led the industry with a share of approximately 60%. the polymer has experienced a substantial surge in the application, specifically in the rapid prototyping of microfluidic devices, credited to the material’s comfort of fabrication into items and reduced price. Moreover, new surface alterations are being launched to resolve the difficulties brought on by the hydrophobicity of polymers.
Hence, the industry for microfluidic devices is boosted by their increasing utilization in genomic and proteomic research.